Correcting mortality for loss to follow-up: A nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa

PLoS Medicine

Volumn 8, Issue 1, 2011, Pages

  Egger, Matthias ^a   Spycher, Ben D ^a   Sidle, John ^b   Weigel, Ralf ^c   Geng, Elvin H ^d   Fox, Matthew P ^e   MacPhail, Patrick ^f   van Cutsem, Gilles ^g   Messou, Eugène ^h   Wood, Robin ⁱ   Nash, Denis ^j   Pascoe, Margaret ^k   Dickinson, Diana ^l   Etard, Jean François ^m   McIntyre, James A ^a   Brinkhof, Martin W G ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b MOI UNIVERSITY   (Kenya)

^c KAMUZU CENTRAL HOSPITAL   (Malawi)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f HELEN JOSEPH HOSPITAL   (South Africa)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h CePReF   (Côte d’Ivoire)

ⁱ Institute of Infectious Disease and Molecular Medicine   (South Africa)

^j Columbia University ^*  (United States)

^k Newlands Clinic   (Zimbabwe)

^l Institut de Recherche pour le Développement/UMR 145 ^*

^m INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FOLLOW UP; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; MORTALITY; NOMOGRAM; PATIENT CARE; UNCERTAINTY; ADULT; AFRICA SOUTH OF THE SAHARA; ALGORITHM; CHILD; DRUG UTILIZATION; EPIDEMIOLOGY; HEALTH CARE QUALITY; PATIENT; STATISTICS;

ADULT; AFRICA SOUTH OF THE SAHARA; ALGORITHMS; ANTI-HIV AGENTS; BIAS (EPIDEMIOLOGY); CHILD; DRUG UTILIZATION; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; NOMOGRAMS; PATIENT DROPOUTS; PROGRAM EVALUATION;

EID: 79951616831     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000390     Document Type: Article

References (31)

1. World Health Organization (2009), Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector. 2009 Progress Report. WHO, Geneva. Available: http://www.who.int/hiv/pub/2009progressreport/en/index.html. Accessed 6 December 2010.
2. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, et al. (2006), The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368: 505-510.
3. Ivers LC, Kendrick D, Doucette K, (2005), Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 41: 217-224.
4. Keiser O, Orrell C, Egger M, Wood R, Brinkhof MW, et al. (2008), Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS Med 5: e148 doi:10.1371/journal.pmed.0050148.
5. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, et al. (2006), Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 296: 679-690.
6. Rosen S, Fox MP, Gill CJ, (2007), Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298 doi:10.1371/journal.pmed.0040298.
7. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, et al. (2008), Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86: 559-567.
8. Brinkhof MW, Pujades-Rodriguez M, Egger M, (2009), Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4: e5790 doi:10.1371/journal.pone.0005790.
9. May M, Boulle A, Phiri S, Messou E, Myer L, et al. (2010), Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 376: 449-457.
10. Grimes DA,(2008), The nomogram epidemic: resurgence of a medical relic. Ann Intern Med 149: 273-275.
11. Porta M,(2008), A Dictionary of Epidemiology. Fifth Edition. Oxford University Press.
12. Anglaret X, Toure S, Gourvellec G, Tchehy A, Zio L, et al. (2004), Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from sub-Saharan Africa. J Acquir Immune Defic Syndr 35: 320-323.
13. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, et al. (2007), True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ 85: 550-554.
14. Dalal RP, MacPhail C, Mqhayi M, Wing J, Feldman C, et al. (2008), Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 47: 101-107.
15. Fox MP, Brennan A, Maskew M, MacPhail P, Sanne I, (2010), Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health 15: 405-413.
16. Dabis F, Balestre E, Braitstein P, Miotti P, Brinkhof WGM, et al. (2005), Antiretroviral Therapy in Lower Income Countries (ART-LINC): International collaboration of treatment cohorts. Int J Epidemiol 34: 979-986.
17. Keiser O, Anastos K, Schechter M, Balestre E, Myer L, et al. (2008), Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health 13: 870-879.
18. Forster M, Bailey C, Brinkhof MW, Graber C, Boulle A, et al. (2008), Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ 86: 939-947.
19. McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, et al. (2007), Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol 36: 969-976.
20. Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, et al. (2007), Cohort profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 36: 294-301.
21. Inui TS, Nyandiko WM, Kimaiyo SN, Frankel RM, Muriuki T, et al. (2007), AMPATH: Living proof that no one has to die from HIV. J Gen Intern Med 22: 1745-1750.
22. Einterz RM, Kimaiyo S, Mengech HN, Khwa-Otsyula BO, Esamai F, et al. (2007), Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med 82: 812-818.
23. Yiannoutsos CT, An MW, Frangakis CE, Musick BS, Braitstein P,(2008), Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One 3: e3843 doi:10.1371/journal.pone.0003843.
24. Frangakis CE, Rubin DB, (2001), Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring. Biometrics 57: 333-342.
25. Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, et al. (2010), Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 53: 405-411.
26. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, et al. (2006), Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296: 782-793.
27. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006), Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet 367: 817-824.
28. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, et al. (2006), Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. Lancet 367: 1335-1342.
29. Boulle A, Bock P, Osler M, Cohen K, Channing L, et al. (2008), Antiretroviral therapy and early mortality in South Africa. Bull World Health Organ 86: 678-687.
30. Geng EH, Emenyonu N, Bwana MB, Glidden DV, Martin JN,(2008), Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300: 506-507.
31. Losina E, Toure H, Uhler LM, Anglaret X, Paltiel AD, et al. (2009), Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: A Cote d'Ivoire appraisal. PLoS Med 6: e1000173 doi:10.1371/journal.pmed.1000173.